Tea polyphenols show antiglycation promise for diabetics
Epigallocatechin-3-gallate (EGCG) could play a role in attenuating low density lipoprotein (LDL) and glycation in high-glucose, diabetes-like conditions, if the results of an in vitro trial hold true in vivo.